Adenocarcinoma of the Extrahepatic Bile Duct Completed Phase 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0030457 (Adenocarcinoma of the Extrahepatic Bile Duct)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs